Next-Gen Stool DNA Test for Colorectal Cancer Has High Detection Rate
Researchers say the test has the best performance for the detection of both colorectal cancer and advanced precancerous polyps.
Researchers say the test has the best performance for the detection of both colorectal cancer and advanced precancerous polyps.
Researchers applied targeted mass spectrometry to show that pancreatic cancer arises through changes in cellular metabolism.
Oncobiomix says it will use Limmi's Disease Insights Platform to power their AI models for predicting prostate cancer risk.
Lucid Diagnostics has contracted with the World Trade Center Health Program to provide the EsoGuard Esophageal DNA test as a covered benefit.
Read MoreThe program started in 2022 when AstraZeneca and Sophia Genetics collaborated to deploy HRD testing to five labs throughout the country.
Read MoreGalleri can identify DNA shed by cancer cells to help screen for some of the deadliest cancers that don’t have recommended screening today.
Read MoreThe funding aims to propel ArteraAI forward in its mission to personalize cancer therapy through AI-enabled predictive and prognostic tests.
Read MoreAgilent will expand its CDx portfolio with novel biomarkers and Incyte will leverage Agilent’s expertise in IVD assay development.
Read MoreThe genetic test evaluates specific genes that offer individuals insights into their genetic profiles and their effects on health and aging.
Read MorePathologists at OSUCCC-James have been evaluating an AI algorithm for the past year. The results are extremely promising.
Read MoreA pilot study proposes a promising clinically applicable genomic assay for the diagnosis of a heterogeneous pediatric leukemia.
Read MoreThe commonly ordered biomarker test is used to guide doctor’s recommendations for patients with estrogen receptor-positive breast cancer.
Read MoreScientists combined machine learning with info on blood metabolites to develop a new test able to detect ovarian cancer with 93% accuracy.
Read MoreThe study will collect small blood samples several times from 150 patients with high-risk neuroblastoma to be examined in laboratories.
Read MoreNew research is guiding the development of blood tests to detect and monitor responses to therapies in neuroendocrine carcinomas patients.
Read MoreThe DecisionDx-SCC test guides adjuvant radiation therapy (ART) decisions for patients with squamous cell carcinoma (SCC).
Read MoreDermaSensor Inc. announced FDA clearance for its real-time, non-invasive skin cancer evaluation system which detects common skin cancers.
Read MoreThe PreveCol test for cancer is aimed at the early detection of biomarkers in blood associated with colorectal neoplasia.
Read More